Why medical cannabis is never prescribed in resin form
Cannabis-based medicinal products (CBMPs) are now prescribed in a variety of forms in the UK. But one product type you won’t find in the formulary is cannabis resin.
Stay updated with the latest trends, news, and developments in the UK medical cannabis industry, from regulations to market growth and innovations.
Cannabis-based medicinal products (CBMPs) are now prescribed in a variety of forms in the UK. But one product type you won’t find in the formulary is cannabis resin.
At Releaf, our mission is to enhance the quality of life of individuals across the UK by giving them back control of their health. And throughout 2024, as well as providing patient-focused care and unwavering support through our expert clinical and patient support teams, we’ve had the privilege of speaking with our patients one on one to find out more about their health journeys.
Explore the potential of medical cannabis in 2025 as an alternative healthcare option in the UK. Learn how Releaf helps patients address health concerns like anxiety, chronic pain, and more with personalised, patient-centred treatment plans. Discover the benefits, conditions eligible for treatment, and how to take the first step toward a healthier you this New Year.
While most people look for alternative treatment options because conventional medicines haven’t met their needs, an increase in prescription drug shortages in the UK is leaving more patients without access to effective medications.
With extended families coming together and immediate families typically spending long periods of time together over the Christmas period, catching up on what everyone has been up to over the last year is a common course conversation takes.
Medical cannabis flower can feel confusing at first, especially if you are new to vaporising. This 2026 guide breaks down the key medical cannabis accessories UK patients commonly use, including dry herb vaporisers, dosing capsules, and grinders for better preparation and more consistent dosing. You will also learn why these tools matter, what to avoid, and how the right setup can make your routine simpler and more reliable.
Growing awareness and acceptance of cannabis-based products has been on the rise in recent years. In addition to a flourishing CBD consumer market, medical cannabis has become increasingly accessible to patients with a variety of health concerns.
This year, we’ve taken a leaf from Spotify’s book and put together a collection of our favourite moments during 2024. As the year draws to a close, here we reflect on our milestones, growth, and most importantly, the transformative difference we’re making for patients.
We know what a difference the right vape can make, that’s why we’ve given out over £115,000 of Omura products to medical cannabis patients in the UK for free.
The holiday season is fast approaching, and with it, the yearly yearning to pack your bags, hit the road and hopefully escape the winter blues.
The days are drawing in and Christmas is right around the corner. Many of us will be working our way down Christmas lists, trying to find the perfect presents for our loved ones.
Around the world, 1.3 billion, or 1 in 6, people live with a disability - yet many face barriers when accessing adequate healthcare services. At Releaf, it's important to us to participate in events like International Day of Persons with Disabilities, and so that’s exactly what we’re doing.
There has been a huge resurgence in interest in plant-based health solutions in the past few decades. Not so long ago, most patients would just take whatever pharmaceutical options their GPs prescribed - but as we mature as a society and our collective understanding of alternative medicine grows, the understanding that plants can offer natural relief from a huge range of symptoms grows.
Disability History Month, taking place from 14 November— 20 December highlights the history of the equality and human rights struggles of disabled individuals in the UK.
As new findings from an early health economic analysis suggest that prescribing medical cannabis on the NHS to treat chronic pain could save the state healthcare provider almost £4 billion every year, we take a closer look at the research.
When we discuss the 'strength' (or potency) of a given medical cannabis cultivar, it is easy to fall into the trap of simply looking at the THC levels. This is only one part of the picture - but a crucial one, nonetheless.
Friday the 1st of November 2024 marks six years of medical cannabis in the UK. For the last six years, (since November 1, 2018) specialist doctors like those working at Releaf have been able to prescribe medical cannabis flower, and cannabis oil, to eligible patients when traditional treatments have proved ineffective.
While awareness of medical cannabis has grown in recent years, there remains a huge knowledge gap when it comes to healthcare professionals and their understanding of this treatment.
Medical cannabis was legalised almost 6 years ago as an alternative treatment option for a large volume of health conditions when conventional approaches have proved ineffective.
Medical cannabis has been prescribed for a wide range of conditions in the UK since the legislation of cannabis-based treatments on the 1st of November 2018. Since then, tens of thousands of patients have received a prescription for cannabis-based medicines; however, there are several conditions, including schizoaffective disorder, for which medical cannabis is not considered a suitable option. But why is this?
The medicinal potential of cannabis and its derivatives has been a focus of medical research for hundreds of years. Yet, there remains a significant number of unknowns around this complex and versatile plant. With that in mind, we’re taking a closer look at some of the most significant medical cannabis research published so far in 2024.
Now that medical cannabis has been legally available in the UK for almost six years, powerful patient testimonials are hitting the press highlighting how medical cannabis has helped people manage PTSD, depression, and anxiety symptoms.
Curious as to who can prescribe medical cannabis in the UK? Well, meet Releaf’s team of specialists, from GPs to specialists n Neurology, Psychiatry, Oncology, Rheumatology and Palliative Care, our clinical team collaborate to create the best bespoke treatment plan possible, for each individual patient.
With a large proportion of Releaf patients choosing the Omura Vaporiser to "heat, not burn" their prescribed medical cannabis flower options, we thought it was about time to quickly discuss how to use the Flowerstick Home Fill System.